4//SEC Filing
Brinkley David L 4
Accession 0001179110-13-009448
CIK 0001080014other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 7:02 PM ET
Size
5.0 KB
Accession
0001179110-13-009448
Insider Transaction Report
Form 4
THERAVANCE INCTHRX
Brinkley David L
Head of Business Dev.
Transactions
- Sale
Common Stock
2013-05-29$35.01/sh−3,808$133,318→ 48,749 total
Footnotes (2)
- [F1]DISPOSITIONS MADE PURSUANT TO A PLAN INTENDED TO COMPLY WITH RULE 10b5-1(c).
- [F2]This transaction was executed in multiple trades at prices ranging from $34.99 to $35.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
THERAVANCE INC
CIK 0001080014
Entity typeother
Related Parties
1- filerCIK 0001302445
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 7:02 PM ET
- Size
- 5.0 KB